December 17, 2014 – 8K

ITEM 7.01 Regulation FD Disclosure

On December 17, 2014, Medizone International, Inc. (the “Company”) posted a “Chairman’s Letter” summarizing recent developments and outlook for the Company.

A copy of the letter to shareholders is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

The information contained in Item 7.01 of this Current Report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

DOWNLOAD THE FULL VERSION OF THE 8-K

SEE THE ONLINE VERSION OF THE CHAIRMAN’S LETTER

Medizone International, Inc. (OTCQB: MZEI)

350 East Michigan Avenue – Suite 500
Kalamazoo, MI 49007

Telephone: (269) 202-5020

Email: [email protected]

Media and Investor Relations:

John Pentony

Medizone International, Inc.

Telephone: (269) 202-5020

Email: [email protected]

Social Media


Twitter:


https://twitter.com/asepticsure